Article thumbnail

Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Recruits Bone Marrow-Derived Cells to the Murine Pulmonary Vasculature

By Daniel J. Angelini, Qingning Su, Irina A. Kolosova, Chunling Fan, John T. Skinner, Kazuyo Yamaji-Kegan, Michael Collector, Saul J. Sharkis and Roger A. Johns
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2889818
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). A family of tissue-specific resistin-like molecules.
  2. (2007). A histological survey of green fluorescent protein expression in ‘green’ mice: implications for stem cell research.
  3. (2008). Adult stem cells and their trans-differentiation potential–perspectives and therapeutic applications.
  4. (2007). Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts.
  5. (2003). Attenuation of chronic hypoxic pulmonary hypertension by simvastatin.
  6. (2006). Bone marrow production of lung cells: the impact of G-CSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype.
  7. (2008). Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension.
  8. (2005). Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxiainduced pulmonary hypertension.
  9. (2007). Bruton’s tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis.
  10. (2001). Circulating smooth muscle progenitor cells contribute to atherosclerosis.
  11. (2000). eNOSdeficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia.
  12. (2004). FIZZ1 stimulation of myofibroblast differentiation.
  13. (2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family.
  14. (2003). FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties.
  15. (1999). Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells.
  16. (2002). Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.
  17. (2006). Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2.
  18. (2006). Hypoxia-induced mitogenic factor promotes vascular adhesion molecule-1 expression via the PI3K/Akt-NF-kappaB signaling pathway.
  19. (2004). Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.
  20. (2009). HypoxiaInduced Mitogenic Factor (HIMF) Is Involved in the Pulmonary Vascular Remodeling Associated with Chronic Hypoxia and Inflammatory Asthma. American Thoracic Society International Conference.
  21. (2009). Hypoxiainduced mitogenic factor (HIMF/FIZZ1/RELMa) induces the vascular and hemodynamic changes of pulmonary hypertension.
  22. (2002). Interaction of Btk and Akt in B cell signaling.
  23. (2003). Plasticity of marrow-derived stem cells.
  24. (2007). Regression of chronic hypoxic pulmonary hypertension by simvastatin.
  25. (2003). Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation.
  26. (1996). Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat.